Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancer

Shiyu Sun(Guizhou Normal University), Xingcong Ma(University of North Carolina at Chapel Hill)
Journal for ImmunoTherapy of Cancer
September 1, 2025
Cited by 3


Related Papers